AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian
J.G. Pereira, MD, President and Chief Executive Officer, will present an
overview of the Company at the Canaccord Adams 29th Annual
Global Growth Conference on Tuesday, August 11 at 9:00 a.m. ET. The
conference is being held August 11-13, 2009 in Boston, MA.
A live audio webcast of the presentation will be accessible through the
Investors section of the Company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website until August 25, 2009.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes
its proprietary technology for the development and commercialization of
a therapeutic iron compound to treat iron deficiency anemia and novel
imaging agents to aid in the diagnosis of cancer and cardiovascular
disease. AMAG recently received approval from the U.S. Food and Drug
Administration to market Feraheme™ (ferumoxytol) Injection for the
treatment of iron deficiency anemia in adult chronic kidney disease
patients. For additional company and product information please visit www.amagpharma.com.
Feraheme™ is a trademark of AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361
